BioSpace News Archive

BioForest

Red Cross Issues Urgent Call for Blood Donations Heading into Holiday Season

21,000 fewer blood donations collected during September and October than needed

November 13, 2018
·
4 min read
BioCapital

AsclepiX Therapeutics Raises $5M in New Funding

Financing will advance clinical development of the Company’s lead product AXT107

November 13, 2018
·
4 min read
China Pharma Holdings, Inc. Launched Health Product Noni Enzyme ARARATO®

China Pharma Holdings, Inc. announced today the launch of its health product Noni Enzyme ARARATO® to the market.

November 13, 2018
·
3 min read
Drug Development

Amplyx Doses First Patient in Phase 2 Trial of APX001 in Patients with Candida Infection

First Patient has Completed Dosing in Global Phase 2 Clinical Trial for the First-Line Treatment of Patients with Candidemia

November 13, 2018
·
3 min read
BioForest

BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences

BioLife Solutions, Inc. today announced that management and scientific personnel will be attending and presenting at the following upcoming events:

November 13, 2018
·
3 min read
Business

Horizon Healthcare Services Inc. selects Geneia to accelerate member-centric healthcare

New Jersey’s largest health plan to use Geneia’s Theon® platform to effectively anticipate and meet the diverse needs of its 3.8 million members

November 13, 2018
·
3 min read
Genetown

Charles River Laboratories Continues Commitment to Oncology Drug Discovery

Team of oncology experts expand data in Tumor Model Compendium and present strong portfolio at industry conferences

November 13, 2018
·
3 min read
Cypress Debuts Ultra-Low-Power Data-Logging Solution for Portable Medical, Wearable and IoT Devices

Cypress Semiconductor Corp. (NASDAQ:CY), the embedded solutions leader, today introduced a nonvolatile data-logging solution with ultra-low power consumption.

November 13, 2018
·
4 min read
Business

Catabasis Pharmaceuticals Reports Third Quarter 2018 Financial Results and Reviews Business Progress

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2018, and reviewed recent business progress.

November 13, 2018
·
11 min read
McGill, Yale and Universities of Pennsylvania and Massachusetts Join PanFAM-1, the Largest Ever Prospective Multicenter Clinical Study for Early Detection of Pancreatic Cancer

New centers give study near complete coverage of North American FPC sites in drive to validate IMMrayTM PanCan-d, the first blood based test for early detection of pancreatic cancer

November 13, 2018
·
4 min read